Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40004146
Localisation
India
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
27/03/2025
Statut
Classification
1.5°C
Année cible
FY2034
Statut
Targets set
Classification
1.5°C
Année cible
FY2050
Overall Net-Zero Target: Alembic Pharmaceuticals Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Alembic Pharmaceuticals Limited commits to reduce absolute scope 1, 2 and 3 GHG emissions 63% by FY2034 from a FY2022 base year. Long-Term Targets: Alembic Pharmaceuticals Limited commits to reduce absolute scope 1, 2 and 3 GHG emissions 90% by FY2050 from a FY2022 base year.
Statut
Targets setAnnée cible
FY2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
INE901L01018
LEI
335800PM173KNG818V30
Source : Science Based Targets initiative | Données publiques